|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Stock-based compensation | |||||
| Non-cash lease expense | |||||
| Depreciation and amortization | |||||
| Non-cash interest expense and other | |||||
| Changes in operating assets and liabilities: | |||||
| Royalty receivable | |||||
| Prepaid expenses and other current assets | |||||
| Operating lease right-of-use asset | |||||
| Accounts payable, accrued compensation, accrued expenses and other current liabilities, and short-term operating lease | |||||
| Long-term operating lease liability | |||||
| Long-term operating lease liability, net of current portion | |||||
| Operating lease liability | |||||
| Net cash used in operating activities | |||||
| Investing Activities | |||||
| Net cash from investing activities | |||||
| Financing Activities | |||||
| Value of equity awards withheld for tax liability | |||||
| Proceeds from exercise of common warrants, net of issuance costs | |||||
| Proceeds from issuance of common stock, pre-funded warrants exercise, and common warrants exercise, net of issuance costs | |||||
| Payments in lieu of fractional shares | |||||
| Net cash provided by financing activities | |||||
| Increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental Cash Flow Information | |||||
| Warrant modification - incremental value | |||||
| Dividend attributable to down round feature of warrants | |||||
| Fair value of December 2024 inducement transaction common warrants | |||||
Loading...